TLRY — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Tilray Brands, Inc.
Healthcare · $6.55
5.1
/10
Neutral
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-31.6%
Below trend
Volatility
Low
Thin premiums
Momentum
Accelerating
Price direction
About Tilray Brands, Inc.
Tilray Brands operates in cannabis, beverages, and wellness. Highly speculative, sentiment-driven, high beta, no dividend. Prone to sharp rallies and selloffs on legalization news. Premiums are rich but assignment risk is substantial — thin margin of safety for CSP sellers in this volatile, hype-prone name.
Drug Manufacturers - Specialty & Generic
Market Cap
$761M
Beta
2.09
52-Week Range Current: $6.55
$3.5 $23.2
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE